ARCHIVES

Oblimersen Combination Improves CLL Survival

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says

October 17, 1997

First Panel Meeting On Centers Generates Possible Recommendations For Core Grant Guideline Changes

April 6, 1984

Children’s Memorial Hospital Receives $3 Million Endowment From Price Trust

May 28, 2010

Brenner To Leave Breast Cancer Action

September 17, 2010

Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time

April 16, 1999

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010